Literature DB >> 18949860

Worldwide progress in introducing pneumococcal conjugate vaccine, 2000-2008.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949860

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN: 0049-8114


× No keyword cloud information.
  5 in total

1.  Intradermal delivery of vaccines: potential benefits and current challenges.

Authors:  J K Hickling; K R Jones; M Friede; D Zehrung; D Chen; D Kristensen
Journal:  Bull World Health Organ       Date:  2011-01-05       Impact factor: 9.408

2.  Economic evaluation of pneumococcal conjugate vaccination in The Gambia.

Authors:  Sun-Young Kim; Gene Lee; Sue J Goldie
Journal:  BMC Infect Dis       Date:  2010-09-03       Impact factor: 3.090

3.  WHO policy development processes for a new vaccine: case study of malaria vaccines.

Authors:  Julie Milstien; Vicky Cárdenas; James Cheyne; Alan Brooks
Journal:  Malar J       Date:  2010-06-24       Impact factor: 2.979

4.  Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England.

Authors:  K E Chapman; D Wilson; R Gorton
Journal:  Epidemiol Infect       Date:  2012-05-08       Impact factor: 4.434

5.  Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study.

Authors:  Zitta B Harboe; Reimar W Thomsen; Anders Riis; Palle Valentiner-Branth; Jens Jørgen Christensen; Lotte Lambertsen; Karen A Krogfelt; Helle B Konradsen; Thomas L Benfield
Journal:  PLoS Med       Date:  2009-05-26       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.